Skip to main content
Log in

Influence of β-cyclodextrin on the Properties of Norfloxacin Form A

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Cyclodextrins are able to form host–guest complexes with hydrophobic molecules to result in the formation of inclusion complexes. The complex formation between norfloxacin form A and β-cyclodextrin was studied by exploring its structure affinity relationship in an aqueous solution and in the solid state. Kneading, freeze-drying, and physical mixture methods were employed to prepare solid complexes of norfloxacin and β-cyclodextrin. The solubility of norfloxacin significantly increased upon complexation with β-cyclodextrin as demonstrated by a solubility isotherm of the AL type along with the results of an intrinsic dissolution study. The complexes were also characterized in the solid stated by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier-transform infrared (FT-IR) spectroscopy, X-ray diffractometry, scanning electron microscopy (SEM), and solid-state nuclear magnetic resonance (ssNMR) spectrometry. The thermal analysis showed that the thermal stability of the drug is enhanced in the presence of β-cyclodextrin. Finally, the microbiological studies showed that the complexes have better potency when compared with pure drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Naumann P, Dopp C. Fluoroquinolones—antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs. Internist (Berl). 1989;30:20–31.

    CAS  Google Scholar 

  2. Sárkozy G. Quinolones: a class of antimicrobial agents. Vet Med. 2001;46:257–74.

    Google Scholar 

  3. Bomma R, Naidu RAS, Yamsani MR, Veerabrahma K. Development and evaluation of gastroretentive norfloxacin floating tablets. Acta Pharm. 2009;59:211–21. doi:10.2478/v10007-009-0019-6.

    Article  CAS  PubMed  Google Scholar 

  4. Deng B, Su C, Kang Y. Determination of norfloxacin in human urine by capillary electrophoresis with electrochemiluminescence detection. Anal Bional Chem. 2006;371(385):1336–41.

    Article  Google Scholar 

  5. United States Pharmacopeia. 35th ed. Rockville: United States Pharmacopoeial Convention, 2012.

  6. Barbas R, Martí F, Prohens R, Puigjaner C. Polymorphism of norfloxacin: evidence of the enantiotropic relationship between polymorphs A and B. Cryst Growth Des. 2006;6:1463–67. doi:10.1021/cg060101u.

    Article  CAS  Google Scholar 

  7. Barbas R, Prohens R, Puigjaner C. A new polymorph of norfloxacin. J Therm Anal Calorim. 2007;89:687–92.

    Article  CAS  Google Scholar 

  8. Puigjaner C, Barbas B, Portell A, Font-Bardia M, Alcobé X, Prohens R. Revisiting of the solid state of norfloxacin. Cryst Growth Des. 2010;10:2948–53. doi:10.1021/cg9014898.

    Article  CAS  Google Scholar 

  9. Szejtli J. Past, present, and future of cyclodextrin. Pure Appl Chem. 2004;76:1825–45.

    Article  CAS  Google Scholar 

  10. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005;6:329–57. doi:10.1208/pt060243.

    Article  Google Scholar 

  11. Szejtli J. Cyclodextrins properties and applications. Drug Invest. 1990;2:11–21.

    Article  Google Scholar 

  12. Marques HC. Applications of cyclodextrins. Rev Port Farm. 1994;44:85–96.

    CAS  Google Scholar 

  13. Ali N, Harikumar SL, Amanpreet K. Cyclodextrin: an excipient tool in drug delivery. Int Res J Pharm. 2012;3:44–50.

    CAS  Google Scholar 

  14. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85:1017–25.

    Article  CAS  PubMed  Google Scholar 

  15. Lee PS, Han JY, Song TW, Sung JH, Kwon OS, Song S, et al. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexes with β-cyclodextrin. Int J Pharm. 2006;316:29–36.

    Article  CAS  PubMed  Google Scholar 

  16. Shen YL, Ying W, Yang SH, Wu LM. Determination of inclusion complex between gossypol and β-cyclodextrin. Spectrochim Acta A. 2006;65:169–72.

    Article  Google Scholar 

  17. Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329:1–11.

    Article  CAS  PubMed  Google Scholar 

  18. Swanson BN, Boppana VK, Vlasses PH, Rotmensch HH, Ferguson RK. Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother. 1983;23:284–88.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm. 1990;63:237–50. doi:10.1016/0378-5173(90)90130-V.

    Article  CAS  Google Scholar 

  20. Tripathi KD. Essentials of medical pharmacology. 40th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 1999.

    Google Scholar 

  21. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm. 1995;123:53–63. doi:10.1016/0378-5173(95)00039-L.

    Article  CAS  Google Scholar 

  22. Fawaz F, Bonini F, Guyot N, Bildet J, Maury M, Lagueny AM. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complex in rabbits. Int J Pharm. 1996;132:271–75. doi:10.1016/0378-5173(95)04387-X.

    Article  CAS  Google Scholar 

  23. Dua K, Ramana MV, Sara UV, Himaja M, Agrawal A, Garg V, et al. Investigation of enhancement of solubility of norfloxacin β-cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv. 2007;4:21–5.

    Article  CAS  PubMed  Google Scholar 

  24. Chattah AK, Mroue KH, Pfund LY, Ramamoorthy A, Longhi MR, Garnero C. Insights into novel supramolecular complexes of two solid forms of norfloxacin and β-cyclodextrin. J Pharm Sci. 2013;102:3717–24. doi:10.1002/jps.23683.

    Article  CAS  PubMed  Google Scholar 

  25. Higuchi T, Connors KA. Phase-solubility techniques. Advances in analytical chemistry and instrumentation. New York: Wiley-Interscience; 1965. p. 117–212.

    Google Scholar 

  26. Harris RK. Nuclear magnetic resonance spectroscopy. London: Logman Scientific and Technical; 1994.

    Google Scholar 

  27. Khitrin AK, Fujiwara T, Akutsub H. Phase-modulated heteronuclear decoupling in NMR of solids. J Magn Reson. 2003;162:46–53. doi:10.1016/S1090-7807(02)00173-8.

    Article  CAS  PubMed  Google Scholar 

  28. Loftsson T, Hreinsdottir D, Masson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 2005;302:18–28. doi:10.1016/j.ijpharm.2005.05.042.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to PACD-FCFAr-UNESP (Araraquara-Brazil), FAPESP process no 2010/13335-2 (São Paulo-Brazil) and CNPQ (Brasília-Brazil) for the fellowships and União Química (Minas Gerais-Brazil) for the financial support. In addition, the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), the Secretaría de Ciencia y Técnica de la Universidad Nacional de Córdoba (SECyT-UNC), and Ministerio de Ciencia y Tecnología (MinCyT) de la Provincia de Córdoba are grateful for the financial support. We also thank Ferromet S.A. (agent of Roquette in Argentina) for their donation of β-cyclodextrin. The cooperation from colleagues at the School of Pharmacy, Virginia Commonwealth University (VCU) is also highly appreciated. We also are grateful to Professor Peter R. Byron from VCU for his help and guidance with the intrinsic dissolution study.

Conflicts of Interest

The authors have declared no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lucas Chierentin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chierentin, L., Garnero, C., Chattah, A.K. et al. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A. AAPS PharmSciTech 16, 683–691 (2015). https://doi.org/10.1208/s12249-014-0259-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-014-0259-8

KEY WORDS

Navigation